U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H36N4O11
Molecular Weight 484.4986
Optical Activity UNSPECIFIED
Defined Stereocenters 15 / 15
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KANAMYCIN A

SMILES

[H][C@]3(O[C@H]1[C@H](N)C[C@H](N)[C@@H](O[C@@]2([H])O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1O)O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O

InChI

InChIKey=SBUJHOSQTJFQJX-NOAMYHISSA-N
InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1

HIDE SMILES / InChI

Molecular Formula C18H36N4O11
Molecular Weight 484.4986
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 15 / 15
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:59:37 UTC 2023
Edited
by admin
on Fri Dec 15 15:59:37 UTC 2023
Record UNII
EQK9Q303C5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KANAMYCIN A
HSDB   MI   WHO-IP  
Common Name English
KANAMYCIN A [MI]
Common Name English
KANAMYCIN A [HSDB]
Common Name English
D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-
Systematic Name English
KANAMYCIN A [WHO-IP]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2363
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
Code System Code Type Description
FDA UNII
EQK9Q303C5
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID3023184
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
CHEBI
17630
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
PUBCHEM
6032
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
CAS
59-01-8
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
MERCK INDEX
m6599
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY Merck Index
NCI_THESAURUS
C76151
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
RXCUI
1727573
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY RxNorm
CHEBI
58214
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
HSDB
3107
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-411-7
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
DAILYMED
EQK9Q303C5
Created by admin on Fri Dec 15 15:59:38 UTC 2023 , Edited by admin on Fri Dec 15 15:59:38 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
Amikacin is a semi-synthetic product derived from a fermentation product, kanamycin A. Amikacin contains not less than 96.5% and not more than 102.0% (Assay, Method A) or not less than 98.5% and not more than 101.0% (Assay, Method B) of amikacin (C22H43N5O13), calculated with reference to the anhydrous substance.
PARENT -> IMPURITY
Amikacin sulfate is a semi-synthetic product derived from a fermentation product, kanamycin A. Amikacin sulfate (1:2) contains not less than 96.5% and not more than 102.0% of amikacin sulfate (C22H43N5O13,2H2SO4), calculated with reference to the dried substance. Amikacin sulfate (1:1.8) contains not less than 96.5% and not more than 102.0% of amikacin sulfate (C22H43N5O13,1.8H2SO4), calculated with reference to the dried substance.
Related Record Type Details
ACTIVE MOIETY